Skip to Main Content

Health Law Policy and Administration Hub
Health Law Archive
Dispute Resolution Services
Career Center
AHLA/LexisNexis Bookstore
Education Center

Join Sign In

Contact
About AHLA
Latest Association News
Donate

Search

Education & Events
Practice Groups
- Practice Groups
- Recent Publications
Communities
- Member Communities
  - My Communities
Publications
Membership
- Activities and Services
- Directories
- Membership Services

January 29, 2024

Health Law Daily

Novo Nordisk To Discontinue Levemir Insulin In US By End Of Year

January 29, 2024

Share this:

facebook
twitter
linkedin

You must be logged in to access this content.

Log in

About AHLA

Contact Us
AHLA Staff
Governance & Leadership
Career Center
Troubleshoot Email Deliverability

Support AHLA

Partnership Opportunities
Donate

News & Resources

Health Law News
Latest Association News
Public Resources
Frequently Asked Questions

Phone:202-833-1100

Contact Us

Privacy Policy Terms of Use Code of Conduct Accessibility Statement

1099 14th Street NW, Suite 925, Washington, DC 20005 | P. 202-833-1100
For payments, please mail to P.O. Box 79340, Baltimore, MD 21279-0340

© 2025 American Health Law Association. All rights reserved.

American Health Law Association is a 501(c)3 and donations are tax-deductible to the extent allowed by law. EIN: 23-7333380